Authors:
Shaughnessy, J
Tian, E
Sawyer, J
Bumm, K
Landes, R
Badros, A
Morris, C
Tricot, G
Epstein, J
Barlogie, B
Citation: J. Shaughnessy et al., High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH, BLOOD, 96(4), 2000, pp. 1505-1511
Authors:
Aguayo, A
O'Brien, S
Keating, M
Manshouri, T
Gidel, C
Barlogie, B
Beran, M
Koller, C
Kantarjian, H
Albitar, M
Citation: A. Aguayo et al., Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemia, BLOOD, 96(2), 2000, pp. 768-770
Authors:
Vesole, DH
Crowley, JJ
Catchatourian, R
Stiff, PJ
Johnson, DB
Cromer, J
Salmon, SE
Barlogie, B
Citation: Dh. Vesole et al., High-dose melphalan with autotransplantation for refractory multiple myeloma: Results of a southwest oncology group phase II trial, J CL ONCOL, 17(7), 1999, pp. 2173-2179
Authors:
Aslan, T
Fassas, AT
Desikan, R
Siegel, D
Munshi, NC
Mehta, J
Singhal, S
Barlogie, B
Anaissie, E
Citation: T. Aslan et al., Patients with multiple myeloma may safely undergo autologous transplantation despite ongoing RSV infection and no ribavirin therapy, BONE MAR TR, 24(5), 1999, pp. 505-509
Authors:
Singhal, S
Mehta, J
Desikan, K
Siegel, D
Singh, J
Munshi, N
Spoon, D
Anaissie, E
Ayers, D
Barlogie, B
Citation: S. Singhal et al., Collection of peripheral blood stem cells after a preceding autograft: unfavorable effect of prior interferon-alpha therapy, BONE MAR TR, 24(1), 1999, pp. 13-17
Authors:
Singhal, S
Mehta, J
Desikan, R
Ayers, D
Roberson, P
Eddlemon, P
Munshi, N
Anaissie, E
Wilson, C
Dhodapkar, M
Zeldis, J
Barlogie, B
Siegel, D
Crowley, J
Citation: S. Singhal et al., Antitumor activity of thalidomide in refractory multiple myeloma., N ENG J MED, 341(21), 1999, pp. 1565-1571
Authors:
Desikan, R
Dhodapkar, M
Siegel, D
Fassas, A
Singh, J
Singhal, S
Mehta, J
Vesole, D
Tricot, G
Jagannath, S
Anaissie, E
Barlogie, B
Munshi, NC
Citation: R. Desikan et al., High-dose therapy with autologous haemopoietic stem cell support for Waldenstrom's macroglobulinaemia, BR J HAEM, 105(4), 1999, pp. 993-996
Authors:
Aguayo, A
Estey, E
Kantarjian, H
Mansouri, T
Gidel, C
Keating, M
Giles, F
Estrov, Z
Barlogie, B
Albitar, M
Citation: A. Aguayo et al., Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia, BLOOD, 94(11), 1999, pp. 3717-3721
Authors:
Feinman, R
Koury, J
Thames, M
Barlogie, B
Epstein, J
Siegel, DS
Citation: R. Feinman et al., Role of NF-kappa B in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2, BLOOD, 93(9), 1999, pp. 3044-3052
Authors:
Barlogie, B
Jagannath, S
Desikan, KR
Mattox, S
Vesole, D
Siegel, D
Tricot, G
Munshi, N
Fassas, A
Singhal, S
Mehta, J
Anaissie, E
Dhodapkar, D
Naucke, S
Cromer, J
Sawyer, J
Epstein, J
Spoon, D
Ayers, D
Cheson, B
Crowley, J
Citation: B. Barlogie et al., Total therapy with tandem transplants for newly diagnosed multiple myeloma, BLOOD, 93(1), 1999, pp. 55-65
Authors:
Dhodapkar, MV
Weinstein, R
Tricot, G
Jagannath, S
Parfitt, AM
Manolagas, SC
Barlogie, B
Citation: Mv. Dhodapkar et al., Biologic and therapeutic determinants of bone mineral density in multiple myeloma, LEUK LYMPH, 32(1-2), 1998, pp. 121-127